- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00714792
Pilot Study: Is Overactive Bladder Caused by Subacute Urinary Tract Infections?
April 26, 2017 updated by: University of Rochester
The purpose of this study is to look for evidence of bacteria in the urine or bladder of people with overactive bladder.
Because you do not have overactive bladder, your participation in this study will be used as a comparison to those who have overactive bladder.
Study Overview
Status
Completed
Conditions
Study Type
Observational
Enrollment (Actual)
18
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New York
-
Rochester, New York, United States, 14642
- Urogynecology and Reconstructive Pelvic Surgery Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
21 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Female
Sampling Method
Non-Probability Sample
Study Population
Urogynecology clinic
Description
Inclusion Criteria:
- Urge urinary incontinence based on clinical history and bladder diary; subjects must have 3 or more urge incontinence episodes/day and 10 or more voids/day.
- 21 years or older
- Healthy volunteers for control subjects
Exclusion Criteria:
- Active cystitis performed on a catheterized urine specimen
- Known or suspected correctable etiology for her urge incontinence
- History of urinary tract stones, foreign bodies or malignancy
- History of recurrent Urinary Tract Infections
- Pregnant women, children
- Evidence of urge urinary incontinence or more than 1 episode of stress incontinence/day by control subject
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
1
Subjects with urge incontinence due to overactive bladder
|
|
2
women with no urge symptoms
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of Subjects With Evidence of Bacteria in Urine Sample by Microbiologic Evaluation
Time Frame: within one week of enrollment
|
Sterile specimens were obtained from subjects.
The urethra was prepared with Betadine and an 8Fr urethral catheter passed into the bladder and urine obtained in a sterile container.
Bladder washings were obtained after urine was completely emptied from the bladder via the catheter.
Saline (60ccs) was used to vigorously irrigate the bladder 2-3 times through the 8 Fr catheter.
The bladder washings were then collected and placed in a sterile container.
The experimental cultures included 100ml inoculated on Blood Agar, MacConkey Agar and Brucella Blood Agar, incubated for 72 hours at 35-37 C in ambient atmosphere supplemented with 5-8% carbon dioxide.
Colonies were counted to quantify the cfu/ml and all growth of any organism was reported.
Organisms were then identified using standard microbiologic techniques.
|
within one week of enrollment
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Michael K. Flynn, MD, University of Rochester
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
June 1, 2008
Primary Completion (Actual)
March 1, 2009
Study Completion (Actual)
March 1, 2009
Study Registration Dates
First Submitted
July 8, 2008
First Submitted That Met QC Criteria
July 11, 2008
First Posted (Estimate)
July 14, 2008
Study Record Updates
Last Update Posted (Actual)
April 28, 2017
Last Update Submitted That Met QC Criteria
April 26, 2017
Last Verified
April 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 23123
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Overactive Bladder
-
Ankara Yildirim Beyazıt UniversityCompletedOveractive Bladder | Overactive Detrusor | Overactive Bladder SyndromeTurkey
-
Pfizer's Upjohn has merged with Mylan to form Viatris...CompletedOveractive Bladder (OAB)United States, Canada, Germany, Korea, Republic of, Spain, Turkey, Taiwan, Italy, Slovakia, Denmark, South Africa, United Kingdom, Mexico, Sweden, Norway
-
Medstar Health Research InstituteColumbia University; University of Michigan; University of New Mexico; Methodist...Terminated
-
Astellas Pharma Global Development, Inc.CompletedOveractive Bladder (OAB)United States, Canada
-
Merck Sharp & Dohme LLCTerminatedOveractive Bladder | Overactive Urinary Bladder
-
Loyola UniversityAstellas Pharma IncCompletedOveractive Bladder SyndromeUnited States
-
Beijing Pins Medical Co., LtdUnknown
-
Maastricht University Medical CenterUnknownLower Urinary Tract Symptoms | Overactive Bladder SyndromeNetherlands
-
Pamukkale UniversityCompletedElectrical Stimulation | Idiopathic Overactive Bladder | Bladder TrainingTurkey